The Asian Scientist 100
Emi Ito
Institution
Osaka University
Country
Japan
Field
Life Sciences
Ito was awarded the 2023 JSPS Ikushi Prize by the Japan Society for the Promotion of Science for her research on unraveling the role of host-derived metabolites in the development of innate-type T cells.
(Photo: Osaka University)
AWARDS
- 2023 JSPS Ikushi Prize
Related articles
Developing Diagnostics In Double-Quick Time
JN Medsys has developed two new coronavirus diagnostic kits to meet the surge in demand for COVID-19 diagnostics.
Lose + Lose = Win
Zooplankton survive over-predation of their food source by switching between two ‘losing’ strategies: laying dormant eggs and staying dormant until algae levels recover.
Cell Membrane Inspires Nanoparticle Computing
The lipid nanotablet platform uses lipid bilayer membranes as a ‘chip’ to control nanoparticles and create nanoparticle-based logic gates.
Priming The World For Primate Conservation (VIDEO)
As countries modernize, habitat destruction can threaten native primate species. Dr. Andie Ang believes that conservation efforts for primates can be strengthened with the right research.
Why Gleevec Could Make Kids Hypersensitive To Smell
The gene Abl, a target of the anti-cancer drug Gleevec, is required for the correct development of the olfactory system.
Eradicating Gastric Cancer With Iridium
Researchers in China have developed a novel drug that could help diagnose and treat gastric cancer.
7 Best Practices From Singapore’s Pandemic Preparedness Playbook
Amid the COVID-19 outbreak, Singapore has won praise for its ‘gold standard’ response. Still, Singaporean medical leaders caution that several critical issues must first be addressed to quell the ongoing epidemic.
Taking Stock Of Poor HPV Vaccine Coverage In Japan
HPV vaccine hesitancy in Japan could result in 5,000 additional deaths from the disease, a study by Japan and Australia scientists suggests.
Advancing Antibody Research
Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.